Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine-processing enzymes are a set of metabolic enzymes that regulate the extracellular and intracellular concentrations of adenosine, a crucial purine nucleoside involved in energy transfer, signal transduction, and neuromodulation. Key enzymes include adenosine deaminase (converts adenosine to inosine), adenosine kinase (phosphorylates adenosine to AMP), and purine nucleoside phosphorylase, as well as ecto-nucleotidases such as ecto-5′-nucleotidase (which generates adenosine from AMP)[1][2][4]. Deficiency or dysregulation of these enzymes is implicated in human disease, including immunodeficiency (ADA deficiency), epilepsy (ADK overexpression), and metabolic, neurological, or inflammatory disorders. Drugs modulating these enzymes can regulate adenosine's tissue-protective, anti-inflammatory, or immunosuppressive effects[2][4].
Enzyme inhibition (e.g., adenosine deaminase inhibitors, adenosine kinase inhibitors) Enzyme replacement Modulation of adenosine bioavailability through transporter blockade
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine-processing enzymes.